Trimen Chemicalssp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Trimen Chemicals supplies reagents and laboratory materials for diagnostics and research, including ELISA kits, antibodies, recombinant proteins, molecular biology reagents and plasmids. The company provides custom synthesis and sources reagents.
Financials
Revenue history (in k)
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 84 days for 2023).
- 2025filed
- 202407/10/2025
- 202307/10/2024
- 202211/08/2023
- 202126/08/2022
- 202010/12/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Public procurement
14 tenders recorded as contractor: 11 national ($76,382) and 3 EU ($46,657).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 29, 2026 | Successive supply of specialist chemical and biological reagents and consumables for cell biology | $1,026$1,026 | Instytut Medycyny Doświadczalnej i Klinicznej Im. Mirosława Mossakowskiego Pan | |
| Oct 27, 2026 | Successive supply of specialist chemical and biological reagents and consumables for cell biology | $304$304 | Instytut Medycyny Doświadczalnej i Klinicznej Im. Mirosława Mossakowskiego Pan | |
| Jun 5, 2026 | Supply of basic chemical compounds for laboratory use, divided into 3 lots under framework agreements | $8,480$8,480 | Sieć Badawcza Łukasiewicz - Port Polski Ośrodek Rozwoju Technologii |
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations of will on behalf of the company are made by the member of the management board. In the case of a multi-member management board, each member of the management board is authorised to perform legal transactions and make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Witold Adam Mozgaage 52 | 2,240 | $30,253.92 | 33.3333% |
Jacek Piotr Olczak | 2,240 | $30,253.92 | 33.3333% |
Przemysław Kazimierz Pilaszekage 50 | 2,240 | $30,253.92 | 33.3333% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Arendisp. z o.o. | 22,285.25 USD | 75% |
Bank accounts
Registered as a VAT taxpayer on 2002-03-28.
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $47,903$47,903 |
Buildings and premises | $12,043$12,043 |
Public aid
4 public aid cases recorded, with a total value of $171,659.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 21, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,699$1,699 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,562$1,562 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Dec 21, 2017 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $85,988$85,988 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2017-12-01 | Carbon-modified salinomycin derivatives at position 1 as precursors for drugs in cancer therapy | $85,988$85,988 | Operational Programme Smart Growth | |
| 2017-12-01 | Salinomycin derivatives modified at carbon position 20 as precursors for drugs in cancer therapy | $82,410$82,410 | Operational Programme Smart Growth | |
| 2016-09-01 | Industrial research and development work conducted by TRIMEN CHEMICALS S.A. on developing a synthesis of optically pure amino acids by asymmetric hydrogenation of aminoacrylates | $161.9K$161,873 | Regional Operational Programme of the Łódź Voivodeship for 2014–2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Eurxsp. z o.o. | $1,644,555.44 | eurx.com.pl | ||
| MPR Labssp. z o.o. | $833,714.20 | mpr-labs.com | ||
| Bioresearch Groupsp. z o.o. | $776,186.19 | bioresearch.pl | ||
| Analytical R & Dsp. z o.o. | $715,583.52 | analytical.pl | ||
| CTI Clinical Trial and Consulting Services Polandsp. z o.o. | $527,145.56 | ctifacts.com | ||
| Farmabolsp. z o.o. | $374,904.90 | farmabol.pl | ||
| CCTSsp. z o.o. | $281,193.31 | ccts.pl | ||
| Medpolmatsp. z o.o. | $257,948.21 | medpolmat.pl | ||
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl | ||
| TCIsp. z o.o. | $218,471.87 | tci.pl |
FAQ
Last updated: 2026-04-10